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of High Risk Groups in Occupational
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Michael Wright*
This conference includes people from many sci-
entific disciplines and people concerned primarily
with policy issues. None of us are experts in all of
those areas. Many of us may have felt that one ses-
sion or another at this conference was out of our
field ofinterest. That's an unfortunate situation, be-
cause more and more, we're going to have to start
making links between the science and the policy.
Those who are concerned primarily with occupa-
tional health policy are going to have to gain a de-
tailed knowledge of the science. Those who are in
scientific research have to begin to recognize the
policy implications ofthe work. Certainly, all of us
have to have a commitment to pursuing both the
science and the policy as honestly and objectively
as we can. Finally, and most important, all of us
have to begin to make this knowledge accessible to
people who are directly concerned-workers in the
mines and mills and factories and labs and
everywhere else. They are the ones whose health
and whose jobs are on the line. They should be the
ones to make the decisions. All of us have the re-
sponsibility to see that we communicate with them
in an honest and effective manner.
Let me explain my biases. In the Steelworker's
Safety and Health Department we are concerned
with the health of our members and of all working
people and we are concerned with the economic
livelihood of our members and all working people.
We don't think our members or anyone else should
have to choose between those things. In the past, a
lot ofour people have been told that they do have to
choose between those things. There are plenty of
examples of companies claiming they will have to
shut down if they are forced to meet OSHA stan-
dards: in other words, they're saying "your money
or your life." So, if some of us are a little worried by
* United Steelworkers of America.
this issue, and ifsome ofus want explicit guarantees
that the identification of high-risk groups will not
result in the loss ofjob or income, I hope you un-
derstand.
I agree about the need for labor-management
cooperation; but let me say also that the lack of
cooperation hasn't come from labor's side. Every
single occupational health standard, including that
for asbestos, and with the exception of DBCP, has
been challenged in court by industry. I suspect that
when OSHA gears up to set a lower asbestos stan-
dard, the asbestos companies will be back in court.
Having stated my biases, let me talk about some
of the things I think we ought to consider this
morning. The first question is to what extent indus-
try will honestly consider the risks to so-called
''nonsusceptibles" as well as the risks to 'suscep-
tibles." Unfortunately, our experience in that area
has not been very good. One example of a wide-
spread genetic screening program is found in some
ofthe lead and chemical companies. There is a very
simple screening test used to exclude certain work-
ers from employment. You look at them and see
whether or not they're female. That's a very simple
program to implement. It doesn't even require an
occupational physician. And if you are a woman
and if you're of childbearing age, and if you have
not been surgically sterilized, you are not allowed to
work around lead or certain chemicals. In other
words, the industry has determined that there is a
risk to potentially pregnant women. The problem is
that many of these companies have not considered
the possibility that male workers are also at risk of
passing on genetic damage to their offspring, and
that men may also suffer reproductive problems. In
other words, these companies are screening out
women and ignoring whatever reproductive effects
may occur in men.
Another, more subtle example ofignoring the risk
to "'nonsusceptibles" is shown by the search for a
good screening test for increased susceptibility to
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ment of the population with increased sensitivity to
TDI. Recent work by John Peters and others at
Harvard indicates that the current OSHA standard
is inadequate, even for the "nonsusceptibles." This
research has been widely ignored. So I think one of
the questions we have to ask is to what extent in-
dustry will consider and eliminate the risk to so-
called 'inonsusceptibles."
Second, to what extent will the policy implica-
tions of the research be honestly discussed and
honestly implemented? Again, I think our experi-
ence with that is not the best. One example is the
discussion which took place yesterday. It was evi-
dent that in some of the population studies pre-
sented, the most important variable genetics, it was
exposure. The clear implication of that research is
that the appropriate action is to reduce environ-
mental exposure, in that it is the greatest risk factor.
Yet, that particular implication wasn't discussed.
We want to know to what extent the implications of
the research will be honestly presented.
Third, to what extent will the negative aspects of
screening be considered? In that light, I'd like to
read from a letter in the Newt England Jouirnal of
Medicine of August 25, 1977. Let me give you the
history of this letter. The authors of the letter had
written a paper on a,-antitrypsin screening and had
indicated that screening for the MZ phenotype
might not be useful. One of the people who was
involved in MZ screening wrote them and said, in
effect, "how can you say this, the screening pro-
grams may actually help us identify a few people,
and we shouldn't be against knowledge." And in
reply, the authors, James Morse of the Veteran's
Administration and Michael Lebowitz and Michael
Knudson of the University of Arizona College of
Medicine discussed one of the negative aspects of
screening: ""Even if the MZ phenotype could be
shown to be one factor predisposing to the de-
velopment oflung disease, it would only be a minor
one compared to the effects of smoking. Although
knowledge ofthe MZ phenotype could at best scare
4 percent of the population into not smoking, the
other 96 percent may only be confirmed in their
habit, now confident that they do not belong to the
unfortunate group ofsusceptibles." To give another
example, what about a plant manager who might
think: "'OK, now we've got rid ofthe susceptibles,
we don't have to worry as much about environ-
mental control." And if you don't think that's a
consideration, let me tell you about a discussion I
had with a plant manager in a small chemical com-
pany some weeks ago during which I pointed out
that some ofthe chemicals they use have reproduc-
tive effects. He said: ""Reproductive effects? No,
we don't have to worry about that, no women work
here." Here was a plant manager who thought they
had screened out the susceptibles, and therefore,
was not worrying about the effects ofthe chemicals
in use. I think that's a real concern for any screen-
ing program. So the third question is, to what extent
do we consider the negative aspects of screening?
The fourth question is, to what extent do we con-
sider the elimination of risk factors rather than the
elimination of workers characterized by the risk
factor? I want to support Dr. Kotin's words, that to
the greatest extent possible, we should try to elimi-
nate the risk factor rather than the worker. I'm a
little concerned at some of the smoking bans in
Johns-Manville and other companies. It seems to
me that simply banning smoking at work is not the
best way to eliminate the risk factor. That's a little
like the Volstead Act. And it could be used to
penalize workers who have trouble quitting. The
best way to eliminate smoking is through an effec-
tive educational campaign. Certainly, the experi-
ence with trying to ban smoking in high school-and
all of us were high school students at one time-
supports that view. I have a question for Dr. Kotin
as to how much he will sit down with the unions
which represent workers in his plants and discuss
the best way to eliminate smoking in that popula-
tion. It may not be by simply banning it on thejob.
Some companies have stated an intention not to
hire workers with a history of smoking. And some
unscrupulous companies may find excuses to get rid
of workers with risk factors, like smoking or mild
pulmonary disease, that might affect the company's
compensation costs. So to what extent will industry
attempt to eliminate the risk factors rather than the
workers?
Numberfive, to what extent will industry use this
susceptibility argument as a way to avoid cleaning
up the workplace? Now, certainly no one will
explicitly say we should use screening as a way to
avoid cleaning up the workplace. On the other
hand, there are indications that some companies
may have that in mind. Certainly, eliminating
smokers from asbestos exposure does not eliminate
the risk ofasbestos-induced lung cancer and it does
not seem to affect the risk of mesothelioma.
Johns-Manville accepts those facts and has made
great efforts to reduce exposure. But in other com-
panies, workers have been told that asbestos will
not hurt you unless you smoke. Another example is
calcium's effect on lead absorption. There still exist
lead smelters where the plant manager goes around
saying, ""Drink lots of milk, because calcium pro-
tects you from lead." No responsible corporate
physician would say that, but plant managers do,
and they're the ones who count. Anotherexample is
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ufactures acrylamide. One of the early signs of ac-
rylamide toxicity is peeling ofthe skin at the finger-
tips. This particular company has a rule that if you
undergo skin peeling three times, you have to be
removed from the acrylamide area. In some cases
this can result in a substantial loss of seniority and
income. The company is assuming that this is a risk
factor of the individual, rather than a result of dif-
ferential exposure, and is screening out individuals
rather than tracking down the exposure. So the fifth
question is to what extent will companies use sus-
ceptibility as a way to avoid cleaning up the work-
place?
Sixth is the question ofjobs. Industry represen-
tatives have indicated that there is no reason for any
of us to believe that screening should cost anyone
their job. I would like to believe that, but consider
the case of women exposed to substances which
may affect reproductive health. Many women have
lost theirjobs because of that. One question I hope
Dr. Kotin addresses today is to what extent
Johns-Manville is willing to guarantee a job to
people removed by screening programs-ajob with
the same rate of pay, the same seniority, and the
same benefits. Is the company willing to guarantee
jobs and earnings protection to those workers? If
not, it seems to me our fears are completely legiti-
mate.
The final question I'd like to ask is to what extent
these things are being done now? Charles F.
Reinhardt, of DuPont, in the May 1978 issue of the
Jouirnal of Occupational Medicine, indicates that
DuPont is now screening for a,-antitrypsin defi-
ciency, G-6-PD, and sickle cell trait. There's
another gentleman here from DuPont. Maybe dur-
ing the discussion, he can tell us more about what
that company's doing. Perhaps Dr. Kilian can tell us
what Dow Chemical Co. is thinking. Those are
some of the questions that I hope we can discuss
today. I'm sure all of you have others.
D. Jack Kilian*
We cannot examine questions about occupational
health policies and practices in relation to high risk
groups without first reminding ourselves that occu-
pational medicine is essentially preventive
medicine. Preventive medicine takes two forms:
Primary prevention is concerned with the preven-
tion of the occurrence of disease, while secondary
prevention tries to prevent the consequences and
sequelae ofdisease or its precursors. While primary
* Dow Chemical Co.
prevention leans heavily on the results of
epidemiological research, secondary prevention,
with which we are concerned today, entails the
definition and identification of ""at risk" and ""high
risk" groups.
It follows, then, that questions about occupa-
tional health policies necessarily involve questions
about the concepts of risk and biologic thresholds.
While it is recognized that reasonable people can
disagree over the concept of zero-threshold for
some substances, we must realize that there is no
such thing as zero risk. Each ofus, from moment to
moment, is a person at risk; as intelligent beings,
the most we can do is to minimize the probability of
adverse effect, without unnecessary sacrifice of
genuine benefit to ourselves and our society.
Following the reasoning of Higginson (In: Per-
sons at High Risk ofCancer, J. Fraumeni, Jr., Ed.,
Academic Press, New York, 1975), we can define
the term, "high risk group" as a population, or set,
that differs from the general population, or universe
set, because it is composed of either individuals
who show an unusual frequency of a specific dis-
ease process or individuals who are exposed to an
unusually high concentration ofa suspected disease
stimulus. In the real world, of course, a high risk
group may be identified by both characteristics. In
addition, we may find that the concept of a group,
rather than being representative of a discrete col-
lection of individuals, is merely a descriptive cate-
gory for persons who are, in fact, scattered
throughout the general population.
In recent years, a number ofrelatively simple and
inexpensive tests have been developed for the pur-
pose ofsingling out high risk groups and subgroups.
Some of these tests-serum a,-antitrypsin (SAT),
glucose-6-phosphate dehydrogenase (G-6-PD),
lymphocyte transformation for isocyanate sensiti-
zation, and the sickle cell assay-hold great prom-
ise in that they will allow identification of those
individuals who are hypersensitive, hyperreactive,
or hypersusceptible to certain environmental
stimuli and, thus, permit initiation of effective pro-
tective and educational intervention strategies.
A recent report on aryl hydrocarbon hydroxylase
inducibility (AHH) concluded that the proportion of
high inducers of this enzyme was significantly
greater among patients with squamous-cell car-
cinoma of the lung than among matched controls
[A. E. Emery et al. Lancet (i): 470 (1978)J. The
proportion of high inducers among patients with
other types of cancer was not significantly greater
than that ofcontrols. In view ofthese results, which
confirm the observations of Kellerman et al. [New
Engl. J. Med. 289: 934 (1973)1 it was suggested that
there may be some individuals who are genetically
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bacco cigarettes. Since cancer of the lung, espe-
cially in males, is the condition most responsible for
a steady rise in the cancer death rate, the potential
usefulness ofthis test for persons in both the indus-
trial environment and the community cannot be
overestimated.
Another recent study reported significant
changes in the circulating blood lymphocytes of
Michigan residents exposed to PBBs [J. Bekesi et
al., Science 199: 1207 (1978)1. Abno'rmalities in-
cluded decreases in the numbers and percentages of
peripheral blood lymphocytes that form rosettes
with either sheep erythrocytes alone or with sheep
erythrocytes sensitized with antibody and comple-
ment, increases in lymphocytes with no detectable
surface markers ( null" cells), and altered re-
sponses to tests, such as reduced lymphoblas-
togenic response to mitogenic stimulation, designed
to evaluate functional integrity of the cells. The
meaning ofthese changes, not found in the blood of
matched controls, is presently unclear, and their
value as a predictor of future health status for the
individual is unknown. It is clear, however, that the
presence of such changes signals the need for care-
ful, followup observation of the PBB-exposed
group.
In recent years, it has become known that many
bacteria and physical states will produce mutations
in plants, bacteria, and animals [M. W. Shaw, Ann.
Rev. Med. 21: 409 (1970)1. Although it is difficult to
prove that specific agents are mutagenic in the
human being, the evidence ofmutagenicity in lower
life forms and the prospect that similar processes
might occur in the human species have become
matters of serious concern to many occupational
physicians. The question of possible chemical
mutagenicity is troubling, first, because of the risk
of damage to the unique genetic heritage that each
of us has received from our ancestors and that we
can pass on to our children and children's children.
Since the human being is a finely-honed product of
many eons of evolution, any change in our genetic
constitution is likely to be disadvantageous. The
possibility of mutagenic response to various stimuli
is also a matter ofconcern to many researchers be-
cause it has been claimed that agents that can cause
mutation are also likely to cause cancer [B. N.
Ames et al., Proc. Natl. Acad. Sci. (U. S.) 70: 228
(1973)].
There are a number of tests available to evaluate
for mutagenic properties in various substances
[Committee 17, Science 187: 503 (1975); A. Hol-
laender, Chemical Mutagens: Principles and
Methods for Their Detection, Vol. 4, Plenum Press,
New York, 19761. Most of these tests rely on ex-
perimental changes induced in plants, bacteria, and
animals. Many investigators consider any extrapo-
lation from these observations to the complex me-
tabolism ofthe human being to be ofdoubtful valid-
ity.
One method ofevaluating for mutagenicity, how-
ever, is based upon the direct observation ofgenetic
material from persons exposed to possible muta-
gens and, thus, may have more than experimental
relevance to the concerns ofoccupational medicine
and environmental health. This method is human
cytogenetic evaluation [D. J. Kilian et al., Ann.
N. Y. Acad. Sci. 269: 4 (1975)1; it is the observation
of chromosomes for visible abnormalities of struc-
ture or number.
Most of us have chromosomal aberrations pres-
ent in the cells of the body from time to time; some
people, as a result of exposure to a chromosome-
breaking agent like ionizing radiation, have a great
many that persist for years [K. E. Buckton et al.,
Lancet ii: 676 (1962)1. While in almost all cases, the
body manages to repair chromosome aberrations, in
some instances, abnormal cell lines are established
[A. A. Awa, in: Chromosomes and Cancer, J. Ger-
man, Ed., Wiley, New York, 1974)1. It has been
found that these abnormal cell lines are sometimes
statistically associated with increased incidence of
serious disease.
Except in a few cases, evaluation of the chromo-
somes of an individual will not allow prediction of
future health status for that person or his/her chil-
dren. On the other hand, evaluation of the fre-
quency of chromosome aberrations in a group has
sometimes revealed an apparent association be-
tween exposure of the group to a chromosome-
breaking agent and an increased frequency of aber-
rations [I. F. H. Purchase et al., Lancet ii: 410
(1975)1. This association warrants concern if com-
parison with a suitable control group shows signifi-
cant differences in aberration rates. The concern is
warranted because it is known that some groups
with a greater-than-usual average number of
chromosome aberrations also have, as a group, a
statistically increased risk of developing cancer.
This association has been seen in atom-bomb sur-
vivors, some worker groups, and in patients treated
for various conditions with chromosome-breaking
drugs and/or radiation; the association is also found
in some disease states, most of which are relatively
rare (J. J. Mulvihill, in: Persons at High Risk of
Cancer, J. Fraumeni, Jr., Ed., Academic Press,
New York, 1975).
Much more study is needed before the value of
cytogenetic evaluation can be widely accepted. One
area of current interest is the sometimes marked
degree of cytogenetic variability from person to
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Little-field and K.-O. Goh, Cytogenet. Cell Genet.
12: 17 (1973)]. Investigations of this phenomenon
are now under way in our laboratory.
The ultimate significance of some tests for inborn
or acquired hypersusceptibility, such as for AHH
inducibility and chromosome aberrations, remains
unclear, but there is enough evidence accumulating,
particularly in regard to cytogenetic evaluation, to
suggest that there is reason for cautious optimism
about their value in the future. Still other tests-like
those to measure immune competency IJ. J. Cos-
tanzi and A. L. Goldstein, Am. Fam. Physician 8:
150 (1973)1-are presently of uncertain value for
purposes of practical intervention, but remain de-
serving of much greater investigatory interest.
In any discussion of occupational health policies
and practices, it is useful to remember that the basic
purpose of preplacement/preemployment examina-
tion is to determine the individual's capacity to
perform a specific range of job-related activities,
with evaluation being directed toward abilities, not
disabilities. Periodic examinations are directed to
the earliest possible detection of health changes in
an essentially healthy person, changes that are to be
expected as part of the inexorable process of aging
(B. D. Dinman, in: The Industrial Environment-Its
Evaluation and Control, NIOSH, GPO,
Washington, D. C., 1973). In regard to both types of
examination we know that the best of engineering
devices can sometimes fail and that the ultimate in
protective equipment is sometimes not used; for
these reasons, competent evaluation of health
status is only prudent. Health and capability deter-
minations, however, are always subject to the in-
herent limitations ofthe physician's ability to detect
biological risk factors and individual susceptibility.
In order to overcome these limitations, the first and
foremost tool that the occupational physician can
employ is the taking of an adequate history, that is,
the ascertainment and recording in usable form of
the pertinent events-occupational, social, familial,
and medical-in the worker's past. Such a history is
invaluable for both initial assessment of an indi-
vidual's health status and in evaluation ofany future
risk.
The advent of specific tests for hypersusceptibil-
ity has lessened the physician's limitations and
augmented the value of a good history by improv-
ing, at least in some situations, the physician's abil-
ity to make judgments of benefit to worker and
management alike. Testing, then, whether for
hearing loss, hernia, or G-6-PD deficiency, is not for
the purpose of ""blaming the victim," ""protecting
the worker out ofhisjob," denying employment, or
restricting opportunity, but rather to facilitate
proper and appropriate job placement.
The widespread belief that cancer, for the most
part, is caused by environmental, or exogenous,
factors has tended to shift attention away from the
need to investigate those endogenous factors that
predispose to the development ofcancer, and other
grave diseases as well. Now, however, as the con-
vening of this conference attests, there is growing
interest in the identification of these endogenous
factors and elucidation of their mechanisms, in the
determination of the degree to which they interact
with exogenous factors, in the isolation of unam-
biguous biologic markers, and, perhaps of greatest
interest to us all, in the development ofinexpensive,
simple laboratory tests suitable for large-scale
screening.
Stokinger and Scheel [J. Occup. Med. 15: 564
(1973)] gave four prerequisites for hypersuscepti-
bility testing in the industrial environment. The first
is that the test should detect an abnormality that is
of relatively high prevalence in the worker popula-
tion; the second is that the abnormality is known to
be affected by substances that are commonly en-
countered by worker populations. The third pre-
requisite is that the abnormality should appear to be
compatible with normal living until occupational
factors enter the picture, and, fourth, that the test
itself should be simple and cheap enough to permit
large-scale use. It should be obvious that the availa-
bility of such tests would be immensely valuable to
the occupational physician in his/her role as a prac-
titioner of preventive medicine, particularly if it is
kept in mind that the purpose ofthe tests should be
the enhancement of proper placement.
For a variety of reasons, however, including the
problem ofcosts and fears about employability, the
available tests for metabolic variation-SAT and
G-6-PD deficiency, CS2 and isocyanate sensitivity,
and for sickle cell trait/anemia-are not widely
used. Other tests, such as cytogenetic evaluation
and lymphocyte transformation, are rarely
employed outside of the clinical setting, and their
significance in terms of the future health status of
the individual remains to be demonstrated. Unfor-
tunately, the lack of utilization has had a chilling
effect on occupational health research and has
tended to perpetuate misconceptions and fears
about the overall aims of preventive medicine and
occupational health.
Although the applicability of a test for AHH in-
ducibility to large-scale screening has not yet been
shown, the potential value of such an assay is very
great. Unfortunately, because of fears about
employability and other societal concerns, it is quite
possible that a test for AHH inducibility or a similar
marker (even ifshown to be fast, simple, cheap, and
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the lack of success of anti-alcohol and anti-tobacco
campaigns in the developed countries, it is even
possible that successful introduction and full utili-
zation of a valid test for hypersusceptibility to pul-
monary irritants will have no appreciable affect on
morbidity and mortality rates ofthe general popula-
tion.
As stated earlier, there is no such thing as zero
risk. The natural history of the human being in na-
ture and in civilization is fraught with danger. It is
clear that the acceptance of the reality of risk, the
desire for benefit, the rational determination to bal-
ance these two factors has characterized civilization
from the first purposeful use offire to the discovery
and use of electricity. Unfortunately, the modifica-
tion of present behavior because of a threat to fu-
ture well-being has never been easy for most per-
sons, and attempts to regulate the life style of indi-
viduals when they themselves do not perceive a
present risk is often regarded as intolerable. Keep-
ing these facts in mind and within these constraints,
we in occupational medicine and environmental re-
search must still manage to carry on with the busi-
ness of life and the protection of health, using sci-
ence and art to reach rationally determined goals.
Nicholas A. Ashford*
Let us begin by asking what it is that we can all
agree upon with regard to high-risk groups. Let us
start there before we ask where we disagree. I think
that it is important to understand and separate the
facts from the policy. First of all, I think Dr. Ki-
lian's division of high-risk groups into two areas is
useful: those which are called, for short, 'hyper-
susceptibles," and those which are highly exposed
groups, the latter being in occupational settings
where the exposure is very high and everyone is
said to be at a high risk. The scientific focus ofthis
conference is on the former group, but we cannot
ignore the latter in discussing policy issues.
We heard this morning from Dr. Kotin that
hypersusceptibility has its origins in genetic factors,
in factors related to life style such as smoking and
nutrition, and in environmental factors. Past occu-
pational history is also an attribute of a worker that
would affect his susceptibility to current occupa-
tional exposure. If he worked in a chemical com-
pany for the first 30 years of his life, and then
moved on to another company which used different
materials or some of the same materials, the
worker's past history certainly would affect his sus-
ceptibility to further development of disease. It is
* Massachusetts Institute of Technology.
important to realize that environmental factors and
past occupational history are both traceable to the
industrial process. Therefore, I would caution you
against the logical fallacy of concluding that if we
identify a worker today who is hypersusceptible due
to factors not related to his current work environ-
ment, this means that his susceptibility is not trace-
able to the industrial process as a result of perhaps
environmental pollutants or his past history of
employment.
What else can we agree upon? The usefulness of
tests for detecting hypersusceptible workers which
identify factors clearly related to occupational dis-
ease is in its infant stage. I would ask: how many
tests that we have heard about at this conference or
that we know of meet the Stokinger criteria'? There
are not very many, and I think that it is interesting
that Dr. Kotin chose to quote this morning from my
book the things that he did not like very much, but
did not quote the next paragraph which says (and it
is a quote from Stokinger), "of the 92 human disor-
ders for which a genetically determined specific en-
zyme deficiency has been identified, only fie are
reported to meet the prerequisites for industrial ap-
plication for better job assignment and improving
coverage of the industrial air limits and hence re-
ducing risk to worker health.''
Dr. Kilian points out that the use of tests for
hypersusceptibility is not widespread, even for
those few that might be more reliable. The worker
himself would indeed benefit from knowledge that
he is in a susceptible group with regard to a specific
occupational hazard, i.e., if the worker himself
knew before he entered a job that it would not be
good for him, particularly, to take the job, that
would be useful knowledge to the worker. At the
same time, labor resists the use ofthese techniques
in placement exams. It is important to understand
why this is the case. In order to maximize profit,
management has an incentive to use the best quality
factors ofproduction, whether they are feedstock or
pieces of metal in metal-stamping plants, or work-
ers. We scrutinize metal parts for defects before we
use them to engineer them into parts, and spend
extensive resources in the production process.
Workers are also considered factors of production;
and it is in the best interest of management to use
the highest quality, highest performing, least
defect-ridden factors of production. That is not
meant to be a nasty statement. It is a statement of
economic rationality. Management not only has an
incentive to maximize profits, it has an incentive to
reduce costs-especially workers' compensation
costs. It has three ways that it can reduce workers'
compensation costs. One way is by removing occu-
pational hazards, and in so doing, management re-
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way in which management meets its goal to reduce
occupational workers' compensation costs is by
removing potential victims ofoccupational disease.
And here, you can reduce high-risk groups by re-
moving the susceptibles. Whether or not reliable
tests can be devised is the focus ofthis conference.
The third way that one can reduce the workers'
compensation costs is to remove potential
claimants-in other words, by firing or not hiring
workers with identifiable disease or precursors of
disease prior to the stage where compensability
would be required. Thus, for example, if a worker
has a chronic respiratory disease but it has not
reached the point of compensability, it is in man-
agement's financial interest to make sure that that
worker no longer works for the corporation.
These are undeniable economic incentives;
whether management chooses to act contrary to its
economic interests in adopting a more ethical posi-
tion is a different issue. I am not saying that all firms
act this way, but I think that we ought to recognize
the stakes and the existing incentives. Is it any
wonder that workers resist taking medical exami-
nations?
What else can we agree on? Physicians working
for management have no common law duty to in-
form workers either that they have a predisposition
to disease, that they have a disease precursor, or
that they have in fact an occupational disease.
There is no common law obligation ofthe physician
employed by management to tell workers these
things. Management itself, as opposed to the physi-
cian, has a duty to warn workers oftheir condition,
but only if the disease will be exacerbated by the
employer's occupational environment. Let me tell
you about a case of an airline pilot who took his
annual physical. He was found to have leukemia
and was not told by the company physician that he
had leukemia. He discovered it three or four years
later and sued the company and the physician for
not informing him that he had leukemia. The case
went against the airline pilot because being
employed in the airline industry has nothing to do
with whether or not his leukemia would be exacer-
bated. That is the state ofthe law. You may not like
it, but that is the way it is.
It is management, and not the physician, that has
the duty to warn, unless the physician assumes a
duty of care for the worker. Then, he is liable for
malpractice ifhe commits malpractice. So the safest
thing for the industrial physician to do is not to give
advice to the worker. Not assuming a duty of care
puts him under absolutely no obligation to tell the
worker anything. Workers, having no warning of ill
health from the firm, may think they are in fact very
healthy because they incorrectly assume that they
would be told ifthere were problems. These are the
realities. I have not talked about motivations, in
terms of ethics; I have only talked about what the
economic incentives are and what behavior is re-
quired under the law. The realities should be well
understood before one bemoans the fear of
employability on the part oflabor, as Dr. Kilian has
expressed, or before one asserts that these tests do
not endanger the worker's employment status, as
Dr. Kotin would have us believe. The point is that
occupational health policies and practices regarding
high-risk groups-that is the title of this session-
are inextricably entwined with management-labor
relations. The ethical duty of the management
physician or the industrial hygienist, in my view,
cannot be discharged with the statement, "I only
conducted the screening tests. I am not responsible
for the way my company exercises its employment
policy."
About a year and a half ago, I attended a New
York Academy ofSciences meeting ofoccupational
physicians, most of whom were industrial physi-
cians. The organizer ofthe conference stood up and
said, "'We are a closed group of people here, and
this is an unofficial meeting. It is not open to the
press. Is there anyone among you in your years of
practice who has ever felt compromised with regard
to his practice of medicine in the industrial set-
ting?" Dead silence. And he continued, "Just as I
thought-another myth shattered!" I hope that I
have convinced you here that there is, in fact, a
conflict of interest. However, if the management
health professional does not believe that he has to
be responsible for the consequences of his science
or practice, then of course he does not feel com-
promised. That is a tautology. It is not, as has been
suggested, the aims of preventive medicine that are
at question here. It is the aims ofemployment pol-
icy. The fact is that the worker has a rationally-
based and real fear that (1) he will be discharged
from his job if he is found to have a disease or a
predisposition to disease, (2) he will be transferred
to a lower-paying job or lose other benefits, and (3)
he will not be employed in another firm once he has
been discharged for health reasons, even ifthe new
place of employment is Free from occupational
hazards. The latter may not be rational industrial
policy, but that is the way it works. Companies do
not want to assume other companies' workers'
compensation costs.
We are the only industrialized country in the
world without a jobs policy or job security policy.
We have 25% ofour workers belonging to unions. It
is probably in labor's interest to have knowledge of
high-risk groups. I stated earlier that it would be
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chemical industry if, for example, they have prior
liver damage. But it would be foolish to let man-
agement do the testing without legally guaranteeing
full disclosure to the worker, a job at equal pay
within the firm, and an aggressive policy ofjob re-
design by management and labor to provide a rea-
sonable number of places for hypersusceptible
workers within the firm. Are these things parts ofan
aggressive employment policy today? No, they are
not. Should it be a concern of people concerned
with the relevant science? In my view, yes.
The Toxic Substances Control Act requires firms
which give these kinds of tests or perform
epidemiology to transmit the health information as-
sociated with toxic materials to EPA. Ifthey do not,
they are in violation of the law for which EPA and
the worker can bring an action, providing ofcourse
that the worker knows. The trouble is that the in-
formation goes to EPA, EPA has to give it to
OSHA, and nobody has to give it to the worker.
Now it is interesting that management advocates
screenings to identify susceptible workers. You
hear this advocated today, even with the paucity of
knowledge and even though techniques are in an
infant stage, according to Stokinger's definition. At
the same time, the very same management groups
resist using Bruce Ames' mutagenicity test to indict
suspect carcinogens. While the screening certainty
is not perfect, it is significantly better than these
screening tests for genetic factors and environmen-
tal factors. Isn't it interesting that there is not an
even-handed approach with regard to what one is
willing to indict on what evidence. That should tell
you something about the likelihood that these tests
are motivated purely by concern for the worker.
These are the realities. Until we either have a na-
tional policy of job security or unless the union
contract protects hypersusceptibles, these tests will
not and, in my view, should not be used by man-
agement to place or replace the worker.
Let me suggest that from a social policy perspec-
tive, we may be focusing on the wrong pathology.
The most serious pathology is misguided industrial
practices. Perhaps we should have or should find a
way to "'screen out" the firms which are especially
susceptible to unfair, unethical practices. The re-
cent attention on discriminatory practices under
various pieces of legislation, including the OSH
Act, the Labor Act, the National Rehabilitation
Act, and the Civil Rights Act, is on the increase
because discriminatory practices are on the in-
crease. I agree with Dr. Kotin that it would be bet-
* Johns Manville Corp.
ter to solve problems in a cooperative and nonad-
versary manner. Unfortunately, with the great im-
balance in both power and knowledge between
labor and management, this isjust not possible on a
wide scale. Until the full reality ofthe consequences
of the policies are realized, we are not going to go
very far.
Paul Kotin*
Let me begin by commenting on some statements
that were made that I think will benefit from elab-
oration. I think Dr. Ashford did not listen when I
indicated that indeed management has a responsi-
bility for a worker, and the issue ofthe worker who
brings pre-existing environmentally determined dis-
ease. I think I did address when I said the second
broad issue is the employer vis-a-vis the govern-
ment, particularly the federal government. Who has
responsibility for a worker not rehireable in his own
field because ofoccupational injury? Miners are the
best example ofthis dilemma. The employer cannot
be held responsible for failing a social obligation
when he refuses to hire a miner with respiratory
impairment even when due to his past mining
employment considering what the current
employer's responsibilities are in the face of the
legislation that exists. I think that there is enough in
the way ofexisting deficiencies and inadequacies in
legislation in this field ofphysical qualifications and
hypersusceptibility for all constituencies to take
constructive and positive steps to correct. It is a
real problem and I did emphasize that there is sig-
nificant element of the problem that is not being
faced. I suggest that perhaps it might be something
that should be explored promptly with legislative
and regulatory entities ofgovernment. Dr. Ashford
persists, and I'm sorry I'm not a better teacher than
I am, in defining and equating hypersusceptibility
with genetic abnormality. All of the genetic abnor-
malities, when weighed against environmental but
non-occupational contributions, represent only a
limited segment of workers at high risk. Actually,
nonoccupational though still environmental con-
tributions are the prime reservoir of high risk. I'm
not talking exclusively about those deficiencies
which are socio-economically related. Certainly, we
would be hard-put to find any abnormality related to
diseases above the diaphragm or below the apical
pleura which did not include again and again refer-
ences to the major determinant that cigarette
smoking represents. So I would hope you will not
leave with the idea that I equate hypersusceptibility
with genetic abnormalities.
My 20 years as a professor of pathology makes it
most difficult for me to accept one thing: I still have
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workforce from the rest of the population exposed
to environmental stresses and the assumption that
workers are immune to the established principles of
biology. Inborn errors of metabolism are very lim-
ited in terms of the population. However, the in-
creased susceptibility associated with premalignant
lesions are, in part, genetically determined. The
work of Warkany, Miller, and Fraumeni is opening
up a whole new frontier in this area in terms of the
relationship of congenital abnormalities to risk of
cancer. The latter day reflections of childhood in-
fectious disease ofthe lung in terms ofthe reactivity
of the lung in the adult is also a factor in hypersus-
ceptibility. And then of course, there are the habits
of cigarette smoking and ethanol ingestion.
Well, I think this adds up to a personal opinion, as
denigrated as the opinions of industrial physicians
have been this morning, that even with virtually
zero exposure, there is no way that these biologi-
cally determined high risks can be eliminated as
much as anybody in this room or as much as I would
like to have them eliminated. It isjust not the nature
ofthe beast. For example, congenital polyposis is a
relatively common congenital abnormality that
should be of concern in relation to cancer of the
colon in those industries where there are sugges-
tions that colon cancer may be occupationally re-
lated. There are, in fact, all sorts of diseases of the
gastrointestinal tract in a large segment of the
population who are at high risk despite their never
having seen the inside of an industrial facility. A
second thing that distresses me is this facultative
use of data, and I can reduce it to one sentence,
elaborating on what I said this morning: occupa-
tional medical surveillance and monitoring data are
viewed differently than the same data obtained im-
mediately prior to employment. We are told to ig-
nore data in the preplacement exam but be respon-
sible after even the briefest period of employment.
It would be nice if biology and the principles of
medicine and health were as accommodating as we
would like them to be in terms of what constitutes
responsible, and' to use your word, Dr. Ashford,
ethical behavior once disease is recognized.
To answer what Mr. Wright asked, yes, we have
a no-smoking program. And let me correct what I
think might have been a misstatement or a partial
statement on my part. Smoking is a hypersuscepti-
bility factor and is going to be a determinant, not in
whether a person keeps ajob, but it does determine
whether he gets thejob. We will hire no smokers in
any activities in which any level of exposure to
pulmonary irritants exists. The corporate policy is
that indeed we do underwrite a kick-the-habit pro-
gram, whether its Smokeenders or one ofthe gener-
ally accepted smoking clinics. We underwrite them
not only for the worker but for his or her spouse, as
the case may be. We've been at it long enough so
that there have been backsliders and we've insti-
tuted a second course. Ultimately, there may be
somebody who is just constitutionally unable to
abandon smoking, where, as a physician, I might
deem that he's a lot worse offby giving up smoking;
it would be hard to think of, but I can accept that as
a possibility. This kind of person would be in no
jeopardy of losing his job as a corollary of that.
Now, let me answer another question I think you
raised, and that is the negative aspects ofscreening.
They exist, but they are far outweighed by the posi-
tive aspects.
Let me just make one more quick comment in
relation to the issue of genetic screening. These
were notes I was taking while Dr. Ashford was
speaking because, again, maybe I can use it as an
example or as an element pertinent to the charge
that it is an excuse to avoid cleaning up the work
place. I work for one company and can't really
speak for all of American industry, but I'll be right
behind you on this.
Now the last thing I want to talk about-and I
wish it hadn't been brought up-is the nonsmoking
asbestos worker with lung cancer. Dr. Selikoff in-
deed reported a four- to fivefold risk oflung cancer
in a nonsmoking nonasbestos worker. The fivefold
increase is, I think, a bit misleading. The figure re-
sults from a ten-year follow-up of 18,000 asbestos
workers in the Insulation Union, which represents
some 300,000 man years. I think the expected figure
was 1.8, the observed was 8.2. The ratio of 8.2 to
1.8 of four to five to one is legitimate, but with a
population of 300,000 man years and a 10-year
follow-up, it is less than a cancer/year. I'm notjus-
tifying or defending the one cancer a year, but basi-
cally, one cannot seriously equate that the double
digit, well-established, multiply confirmed obser-
vations that Selikoff has on the relationship of
cigarette smoking to lung cancer in asbestos work-
ers. Since you brought up asbestos as unique, there
are cases ofuranium miners who have cancer ofthe
lung who don't smoke. But again, the ratios of
smokers and nonsmokers are orders of magnitude.
And while the data forcoke-oven workers are not as
detailed, we again see great differences. This 5:1
ratio really has to be more carefully examined and
not just accepted at face value.
I would like to conclude by saying that in princi-
ple, I have heard nothing from Mr. Wright or any of
the panelists this morning with which I disagree. I
think we must retain discrimination and discipline in
addressing science. If Dr. Ashford, as he's pointed
out, really wishes to address these issues from the
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ethical attitudes, I would be delighted to do so. But
General Discussion
DR. DAWSON (Harvard Univ.): I would like to get a little bit
more ofthe feel ofthe comparison betweenenvironmental health
considerations and occupational health considerations. The par-
ticular question I have deals with two standards. It's my under-
standing that the industrial standard now for a short-term NO2
exposure is 10 ppm, and there's a proposal in to have it become 1
ppm. On the other hand, it has been advocated by the World
Health Organization and others, that the environmental standard
should be 0.1 ppm and I should say, by the way, that EPA is
discussing a range of 0.25 ppm of NO2. Ijust wonder a little bit
about the difference I see in industrial discussions and environ-
mental discussions.
DR. ASHFORD: I'm not sure I can answer your question.
Historically, the fact that occupational standards have not been
as protective as environmental standards is a matter ofrecord-
SO2, lead, other things. That's because the industrial conscious-
ness has been not prevalent, and only recently has labor collec-
tively begun to understand the implications of occupational ex-
posure. Now, the question of whether we should adopt a more
protective standard in the occupational environment rather than
the external environment goes to how much cost/benefit analysis
you think you want to do. In a work place which produces a
product which is necessary for society, you could see a policy
being established which would tolerate much higher concentra-
tion than the effluents which could be easily collected without
destroying the production of the process. I don't want to be
misunderstood as advocating that. I'mjust stating that the game
that you play with regard to finding the acceptable standard
within the workplace, as opposed to external, applies to what the
social product is, and the consideration as to who is affected. It
would also be perfectly consistent to make the internal environ-
ment more protective than the external environment because it's
a special group of people-workers, very often in a lower
socioeconomic class-that end up being the victims, rather than
the population as a whole. So, depending upon what your values
are, the workplace should be made either more protective or less
protective; but I see those as the considerations that enter into
the decision.
MR. WRIGHT: It seems like we have time for one ortwo more
questions.
PARTICIPANT (not identified): Earlier this morning Dr. Kotin
stated that management had a moral imperative-I think those
were his words-to be concerned about the hypersensitive
worker, and, presumably, by screening and change ofjob place-
ment, or-as suggested by his later remarks-job denial, to deal
with that. I would like to ask him if he sees perhaps an even
higher moral imperative on the part of management to work to
limit the exposures to as low an extent as possible in order to
clean up the workplace. The other distinction he seems to be
making this morning was between situations that are uncorrecta-
ble as far as management is concerned. What management can
do about the health ofthe individual worker is limited. Certainly
the exposures in the workplace ought to be correctable by man-
agement.
DR. KOTIN: Can I just answer it with one word? Yes. Man-
agement has a responsibility to apply technology and engineering
controls. There is nothing that I said that would in anyway ques-
tion that principle or support the contrary principle that it is
either or. It must be both, and I guess what I'm concerned about
I think, then, we would probably do a disservice to
that approach by the use of superficial science.
is that there's too much in the way ofa willingness to accept only
one of the two elements, the control only, and not the other,
worker selection. The practice ofmedicine at the highest level of
preventive medicine requires recognition of the individuality of
each person, in this case the worker.
PARTICIPANT (not identified): The single greatest risk to
young nonwhites between ages of 18 and 24 is death by violence.
This has ahigh correlation with unemployment, and these are the
same people who by virtue of the concentration of genetic de-
fects in minority groups and the exposure to such conditions as
nutrition deficiency and generalized environmental pollutants
would be screened out. It seems to me that they face a greater
risk in having a screening program than in not having a screening
program.
DR. KOTIN: First of all, you have stated a situation I wish I
could articulate as well as you did; however, I must add to the
position you take. I fully recognize that the ability to screen
workers is not linearly related, probably has some correlation
with the size of the employer and the extent and scope of his
medical program; so that a person who would be denied
employment might very well go to a '"small business," whatever
that is. He may be no less honest, no less ethically motivated
than the big business, but the tools at hand for identifying the
susceptible worker or the tools at hand for maintaining a maxi-
mally protective environment are probably less in scope and ef-
fectiveness. So, I'm not only agreeing with you, but I'm giving
you one more arrow in your quiver, as it were to call attention to
the issue of the hypersusceptible worker.
PARTICIPANT (not identified): Well, there's a problem
though, because the number ofsmall businesses is dropping, and
our economy is such that businesses employing large numbers of
people are employing a greater percentage of the populace.
DR. KOTIN: You'd have to measure the decline and disap-
pearance ofsmall business with the anthropologist's yardstick in
the measure oftime, rather than the average calendar. I think the
Department ofCommerce data would strongly support my posi-
tion.
DR. ASHFORD: I think this only underscores the fact that we
desperately need a jobs policy in this country. It's not an acci-
dent that Sweden, which has an active fullemployment policy, or
Japan, which has a tradition of employment, in some industries
has a better record with regard to these kinds of situations. I
think you can't get away from looking with an employment pol-
icy with this factor.
DR. SHANKER (Neit' England Medical Center): I'd like to
comment on something that was touched on; that is, the use of
SAT screening. I'm in favor of looking at that measure to see
whether it may be significant prospectively or retrospectively in
terms of interaction with industrial exposures. I think that some
people may be overstating the present state ofthe art when they
consider this to be some type-particularly the heterozygote-
some type of risk for pulmonary disease that may be used in
classifying those workers who may be heterozygotes as hyper-
susceptible. That information doesn't exist. Where these people
stand in terms of developing obstructive airway disease is not
known right now. I wonder ifanyone would like to comment on
using this marker now as a screen for so-called hypersusceptible
workers.
DR. KOTIN: There is perhaps more than one reason why you
would want to incorporate a screen into the program. Let me
give you an example. At my corporation we have what I believe
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sophisticated cytopathology-pulmonary cytopathology screening
program in the world. We really don't know yet whether this is
going to make any difference at all on the natural history ofany
disease that may be discovered. But, nevertheless, it serves the
dual purpose of first identifying people at increased risk, and
secondly it provides a high risk population which can more
rapidly and perhaps, more convincingly demonstrate the utility
of this screening program. I would assume the same thing may
very well apply to not only SAT or AHH but to anyone of a
variety of markers of hypersusceptibility whether congenital or
acquired. It's again in the best time-honored tradition ofapplica-
tion of diagnostic and clinical medical research.
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